Fierce Pharma
DECEMBER 2, 2024
Shortly after a similarly sized venture from Pfizer, French pharma juggernaut Sanofi has unveiled a major manufacturing outlay in China, marking its biggest investment in the country to date. The new manufacturing site, which will become Sanofi’s fourth in China, is being designed to beef up local end-to-end insulin production.
Fierce Pharma
SEPTEMBER 24, 2024
Flush with new business, Philadelphia-based CDMO PCI Pharma Services is blueprinting multiple manufacturing outlays on both sides of the Atlantic. | Altogether, PCI’s manufacturing projects represent an investment of more than $365 million.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Fierce Pharma
SEPTEMBER 20, 2024
Fierce Pharma Asia—Merck's collabs with Daiichi, Eisai deliver readouts; Granules hit with FDA manufacturing observations aliu Fri, 09/20/2024 - 09:21
Fierce Pharma
MARCH 30, 2023
Fierce Pharma Asia—Takeda's manufacturing expansion; Leqembi's sales prospects; GSK's PrEP generics aliu Thu, 03/30/2023 - 16:18
Fierce Pharma
NOVEMBER 20, 2024
On the back of several strong quarters and a year already chock-full of manufacturing accords, Korean CDMO Samsung Biologics is adding yet another project to its contract manufacturing Rolodex. Samsung Biologics said it inked a series of production pacts with an unnamed European pharma in a tie-up worth a total of $668 million.
Fierce Pharma
NOVEMBER 2, 2023
The days of booming COVID-19 vaccine sales, which sent Moderna into the ranks of pharma's top companies, have | The company is focusing on scaling back its manufacturing efforts to cope with the lack of COVID-19 vaccine demand.
Fierce Pharma
NOVEMBER 21, 2023
Texas has accused Pfizer and manufacturer Tris Pharma of knowingly providing compromised ADHD medicine to a state Medicaid program for children of low-income families. | In its lawsuit, Texas says the companies knew that deficient manufacturing processes compromised the effectiveness of Quillivant XR.
Expert insights. Personalized for you.
181 
Let's personalize your content